{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:57:53Z","timestamp":1781351873605,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003454","name":"Guangxi Zhuang Region Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003454","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jgar.2026.03.008","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:54:49Z","timestamp":1773942889000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative colistin sulfate vs. polymyxin B in patients with carbapenem-resistant organism bloodstream infections"],"prefix":"10.1016","volume":"48","author":[{"given":"Yingxia","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huansheng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiquan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.03.008_bib0001","article-title":"Comparative analysis of 30-day and 1-year mortality in carbapenem-resistant versus non-carbapenem-resistant Enterobacterales bacteremia","author":"Foo","year":"2025","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.jgar.2026.03.008_bib0002","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40121-021-00408-8","article-title":"The impact of carbapenem resistance on mortality in patients with Klebsiella pneumoniae bloodstream infection: an individual patient data meta-analysis of 1952 patients","volume":"10","author":"Maraolo","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"11","key":"10.1016\/j.jgar.2026.03.008_bib0003","first-page":"74","article-title":"Mathematical modelling of synergistic triple-antibiotic therapy against carbapenem-resistant Acinetobacter baumannii at clinically achievable concentrations","author":"Huynh","year":"2025","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2026.03.008_bib0004","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jgar.2026.03.008_bib0005","first-page":"597","article-title":"CHINET surveillance of bacterial resistance across China","volume":"25","author":"Guo","year":"2025","journal-title":"Chin J Infect Chemother"},{"key":"10.1016\/j.jgar.2026.03.008_bib0006","first-page":"292","article-title":"Multidisciplinary expert consensus on rational clinical application of polymyxins antibiotics in China","volume":"44","year":"2021","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"8","key":"10.1016\/j.jgar.2026.03.008_bib0007","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s40121-025-01176-5","article-title":"Colistin sulfate-based combination therapy for infections caused by carbapenem-resistant organisms in Intensive care units: a multicenter, prospective, observational clinical trial","volume":"14","author":"Zhang","year":"2025","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jgar.2026.03.008_bib0008","article-title":"Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections","volume":"9","author":"Lu","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"20","key":"10.1016\/j.jgar.2026.03.008_bib0009","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.21037\/atm-22-4959","article-title":"Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant Gram-negative bacterial infections: a retrospective cohort study","volume":"10","author":"Jin","year":"2022","journal-title":"Ann Transl Med"},{"issue":"10","key":"10.1016\/j.jgar.2026.03.008_bib0010","article-title":"Combination regimens with colistin sulfate versus colistin sulfate monotherapy in the treatment of infections caused by carbapenem-resistant Gram-negative bacilli","volume":"11","author":"Hao","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.jgar.2026.03.008_bib0011","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.21037\/jtd-23-336","article-title":"Efficacy and safety of colistin sulfate in the treatment of infections caused by carbapenem-resistant organisms: a multicenter retrospective cohort study","volume":"15","author":"Peng","year":"2023","journal-title":"J Thorac Dis"},{"issue":"5 Suppl","key":"10.1016\/j.jgar.2026.03.008_bib0012","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1097\/01.CCM.0000126124.41743.86","article-title":"Endpoints in sepsis trials: more than just 28-day mortality?","volume":"32","author":"Vincent","year":"2004","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jgar.2026.03.008_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biomet\/asac054","article-title":"Propensity scores in the design of observational studies for causal effects","volume":"110","author":"Rosenbaum","year":"2022","journal-title":"Biometrika"},{"issue":"1","key":"10.1016\/j.jgar.2026.03.008_bib0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.jgar.2026.03.008_bib0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Critical Care"},{"issue":"1","key":"10.1016\/j.jgar.2026.03.008_bib0016","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"7","key":"10.1016\/j.jgar.2026.03.008_bib0017","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3855\/jidc.18887","article-title":"Real-world data on the effects of colistin sulfate and polymyxin B sulfate in the treatment of pneumonia induced by CR-GNB","volume":"18","author":"Liu","year":"2024","journal-title":"J Infect Dev Ctries"},{"issue":"8","key":"10.1016\/j.jgar.2026.03.008_bib0018","first-page":"12","article-title":"Comparison between colistin and polymyxin B in the treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus complex","author":"Garcia","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2026.03.008_bib0019","article-title":"Colistin sulfate versus polymyxin B for the treatment of infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter retrospective cohort study","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jgar.2026.03.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107031","article-title":"Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: a real-world, retrospective cohort study","volume":"63","author":"Zhang","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.jgar.2026.03.008_bib0021","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/phar.4601","article-title":"Acute kidney injury with intravenous colistin sulfate compared with polymyxin B in critically ill patients: a real-world, retrospective cohort study","volume":"44","author":"Yang","year":"2024","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.jgar.2026.03.008_bib0022","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/AAC.02476-13","article-title":"In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy","volume":"58","author":"Phe","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jgar.2026.03.008_bib0023","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1186\/s12879-024-09759-2","article-title":"Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins","volume":"24","author":"Aysert-Yildiz","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2026.03.008_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105328","article-title":"Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury","volume":"163","author":"Sisay","year":"2021","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.jgar.2026.03.008_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12882-024-03551-9","article-title":"Attributable mortality of acute kidney injury among critically ill patients with sepsis: a multicenter, retrospective cohort study","volume":"25","author":"Wang","year":"2024","journal-title":"BMC Nephrol"},{"issue":"10","key":"10.1016\/j.jgar.2026.03.008_bib0026","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/rccm.201310-1875OC","article-title":"Association between source of infection and hospital mortality in patients who have septic shock","volume":"189","author":"Leligdowicz","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jgar.2026.03.008_bib0027","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40364-023-00450-3","article-title":"Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study","volume":"11","author":"Oussalah","year":"2023","journal-title":"Biomark Res"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652600041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652600041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:28:56Z","timestamp":1781350136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371652600041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"alternative-id":["S221371652600041X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.03.008","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative colistin sulfate vs. polymyxin B in patients with carbapenem-resistant organism bloodstream infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}